Pharma Foods International Co., Ltd.
Notice of Formulation of the Medium-Term Management Plan 2029 “1K Project – SPRING Strategy -“
Formulated the Medium-Term Management Plan 2029 "1K Project - SPRING Strategy -". Promote new value creation domains (drug discovery, textiles, and agri) and pursue growth and strengthening of the financial base through M&A. Set targets of 72,000 million yen in net sales, 4,100 million yen in operating income, and EPS of 111 yen. Promote creation of medical foods through M&A.
Key Figures
- Net sales target: 72,000 million yen
- Operating income target: 4,100 million yen
- EPS target: 111 yen
AI要約
Framework of the Medium-Term Management Plan 2029
Formulated the Medium-Term Management Plan 2029 "1K Project - SPRING Strategy -". Actively develop drug discovery, textiles, and agri as new businesses to become the next pillars. Stabilize and return the core businesses to positive operating cash flow to strengthen the financial base. Accelerate growth by leveraging continuous M&A.
Financial Targets and Outlook for New Value Creation
The targets for the fiscal year ending July 2029 are net sales of 72,000 million yen, operating income of 4,100 million yen, operating cash flow of 3,400 million yen, and EPS of 111 yen. Sales growth is assumed to expand through promotion of the 1K Project and utilization of M&A. Going forward, the company will simultaneously promote profitability improvement of existing businesses and expansion of new domains.
Pharma Foods International Co., Ltd.
Company overview · Stock price · Financial data · All IR
